Protease-Activated Receptor-2 (PAR2) in Human Gastric Mucosa as Mediator of Proinflammatory Effects in Helicobacter pylori Infection

被引：5
|
作者：
Kandulski, Arne [1 ]
Kuester, Doerthe [2 ]
Moenkemueller, Klaus [1 ,3 ]
Fry, Lucia [1 ,3 ]
Malfertheiner, Peter [1 ]
Wex, Thomas [1 ]
机构：
[1] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany
[2] Otto Von Guericke Univ, Inst Pathol, D-39120 Magdeburg, Germany
[3] Marienhosp Bottrop, Dept Internal Med, D-46236 Bottrop, Germany
来源：
HELICOBACTER | 2011年 / 16卷 / 06期
关键词：
Cytokines; inflammation; protease; RT-PCR; LOW-DOSE ASPIRIN; EPITHELIAL-CELLS; INFLAMMATION; INHIBITOR; DISEASE; CANCER; INTERLEUKIN-8; IMMUNITY;
D O I：
10.1111/j.1523-5378.2011.00866.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Introduction: Protease-activated receptors (PAR) are seven transmembrane receptors that are expressed throughout the gastrointestinal tract. In vitro experiments using gastric tumor cell lines, murine models and one clinical study provided evidence for a potential role of PAR2 in Helicobacter pylori-induced gastritis.
引用
收藏
页码：452 / 458
页数：7
相关论文
共 50 条
  • [1] PROTEASE-ACTIVATED RECEPTOR-2 (PAR2) IN HUMAN GASTRIC MUCOSA AS MEDIATOR OF PROINFLAMMATORY EFFECTS IN H. PYLORI-INFECTION
    Wex, T.
    Kandulski, A.
    Kuester, D.
    Moenkemueller, K.
    Fry, L. C.
    Malfertheiner, P.
    HELICOBACTER, 2011, 16 : 124 - 124
  • [2] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [3] Protease-activated receptor-2 (PAR2) in the airways
    Cocks, TM
    Moffatt, JD
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) : 183 - 191
  • [4] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [5] Multiple roles for protease-activated receptor-2 in gastric mucosa
    Kawabata A.
    InflammoPharmacology, 2002, 10 (4-6) : 343 - 349
  • [6] Does protease-activated receptor-2 (PAR2) influence muscle development and regeneration?
    Esfandouni, N. Taghavi
    Mackie, E.
    Pagel, C.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S218 - S219
  • [7] Predictive value of protease-activated receptor-2 (PAR2) in cervical cancer metastasis
    He, Shengnan
    Xu, Meiquan
    Xiong, Zhen
    Hu, Ye
    Huo, Qin
    Lu, Jingxiao
    Lin, Yuntao
    Yang, Lan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1415 - 1424
  • [8] Toward Drugs for Protease-Activated Receptor 2 (PAR2)
    Yau, Mei-Kwan
    Liu, Ligong
    Fairlie, David P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7477 - 7497
  • [9] Protease-Activated Receptor-2 (PAR2)-A Novel Therapeutic Target in Nonalcoholic Steatohepatitis (NASH)
    Shearer, Andrew M.
    Austin, Karyn
    Guha, Srijoy
    Nga Nguyen
    Looby, Richard
    Clappin, Allyson
    Baleja, James
    Covic, Lidija
    Kuliopulos, Athan
    HEPATOLOGY, 2014, 60 : 587A - 587A
  • [10] Selective effects of chronic hypertension on cerebral artery responses to protease-activated receptor-2 (PAR2) activation
    Sobey, CG
    Moffatt, JD
    Cocks, TM
    FASEB JOURNAL, 1999, 13 (05): : A1088 - A1088
12345